Applied Dna Sciences (NASDAQ:BNBX) Shares Down 5.8% – Time to Sell?

Applied Dna Sciences Inc (NASDAQ:BNBX)’s stock price fell 5.8% on Monday . The company traded as low as $0.4795 and last traded at $0.5551. 35,758,480 shares traded hands during trading, an increase of 5,769% from the average session volume of 609,245 shares. The stock had previously closed at $0.5890.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings began coverage on shares of Applied Dna Sciences in a research report on Monday, January 26th. They set a “sell (e+)” rating for the company. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Applied Dna Sciences Stock Down 5.8%

The firm has a market cap of $3.15 million, a P/E ratio of 0.00 and a beta of 0.72. The business has a fifty day moving average of $0.71.

Applied Dna Sciences (NASDAQ:BNBX) last released its earnings results on Friday, December 19th. The company reported $122.52 earnings per share (EPS) for the quarter. The business had revenue of $0.20 million for the quarter.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.